FDA Drug Recalls

Recalls / Class II

Class IID-0091-2026

Product

Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Synergy Wellness, 20 mg, 10mL vial lyophilized.

Affected lot / code info
Lot#: GG021125-001, GG031125-017, within expiry.

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
GenoGenix LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2840 Nw 2nd Ave Ste 204, Boca Raton, Florida 33431-6692

Distribution

Distribution pattern
US Nationwide.

Timeline

Recall initiated
2025-07-30
FDA classified
2025-10-21
Posted by FDA
2025-10-15
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0091-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls